Skip to main content
  • Conference proceedings
  • © 2008

Ovarian Cancer

State of the Art and Future Directions in Translational Research

  • Meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 622)

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (23 papers)

  1. Front Matter

    Pages i-xi
  2. Ovarian Cancer Detection and Pathogenesis

    1. Potential and Limitations in Early Diagnosis of Ovarian Cancer

      • Nicole Urban, Charles Drescher
      Pages 3-14
    2. Classification of Ovarian Cancer: A Genomic Analysis

      • Michael P. Stany, Tomas Bonome, Fred Wamunyokoli, Kristen Zorn, Laurent Ozbun, Dong-Choon Park et al.
      Pages 23-33
    3. Epigenetic Markers of Ovarian Cancer

      • Caroline A. Barton, Susan J. Clark, Neville F. Hacker, Philippa M. O’Brien
      Pages 35-51
    4. Role of Genetic Polymorphisms in Ovarian Cancer Susceptibility: Development of an International Ovarian Cancer Association Consortium

      • Andrew Berchuck, Joellen M. Schildkraut, C. Leigh Pearce, Georgia Chenevix-Trench, Paul D. Pharoah
      Pages 53-67
    5. MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatment

      • Lin Zhang, Nuo Yang, George Coukos
      Pages 69-78
    6. Ovarian Carcinogenesis: An Alternative Hypothesis

      • Jurgen M. J. Piek, Paul J. van Diest, René H. M. Verheijen
      Pages 79-87
    7. BRCA1-Induced Ovarian Oncogenesis

      • Louis Dubeau
      Pages 89-97
    8. Role of p53 and Rb in Ovarian Cancer

      • David C. Corney, Andrea Flesken-Nikitin, Jinhyang Choi, Alexander Yu. Nikitin
      Pages 99-117
    9. Ovulatory Factor in Ovarian Carcinogenesis

      • William J. Murdoch
      Pages 119-128
  3. Ovarian Cancer Therapeutics

    1. Ovarian Cancer: Can We Reverse Drug Resistance?

      • David S. P. Tan, Joo Ern Ang, Stan B. Kaye
      Pages 153-167
    2. Syngeneic Mouse Model of Epithelial Ovarian Cancer: Effects of Nanoparticulate Paclitaxel, Nanotax®

      • Katherine F. Roby, Fenghui Niu, Roger A. Rajewski, Charles Decedue, Bala Subramaniam, Paul F. Terranova
      Pages 169-181
    3. Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients

      • Mandi M. Murph, Debra L. Smith, Bryan Hennessy, Yiling Lu, Corwin Joy, Kevin R. Coombes et al.
      Pages 183-195
    4. Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer

      • Karen M. Hajra, Lijun Tan, J. Rebecca Liu
      Pages 197-208
    5. Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy

      • Janet A. Sawicki, Daniel G. Anderson, Robert Langer
      Pages 209-219
    6. Biological Therapy with Oncolytic Herpesvirus

      • Fabian Benencia, George Coukos
      Pages 221-233
    7. Cancer Immunotherapy: Perspectives and Prospects

      • Sonia A. Perez, Michael Papamichail
      Pages 235-253

About this book

Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.

The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.

Editors and Affiliations

  • University of Pennsylvania Medical Center, Philadelphia, USA

    George Coukos

  • Duke University Medical Center, Durham, USA

    Andrew Berchuck

  • Fox Chase Cancer Center, Philadelphia, USA

    Robert Ozols

Bibliographic Information

  • Book Title: Ovarian Cancer

  • Book Subtitle: State of the Art and Future Directions in Translational Research

  • Editors: George Coukos, Andrew Berchuck, Robert Ozols

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-0-387-68969-2

  • Publisher: Springer New York, NY

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2008

  • Hardcover ISBN: 978-0-387-68966-1Published: 09 May 2008

  • Softcover ISBN: 978-1-4419-2396-7Published: 19 November 2010

  • eBook ISBN: 978-0-387-68969-2Published: 06 June 2008

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XII, 308

  • Topics: Oncology, Cancer Research, Life Sciences, general

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access